5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.92▼ | 6.02▼ | 6.02▼ | 6.04▼ | 5.58▲ |
MA10 | 5.94▼ | 6.06▼ | 6.17▼ | 5.77▲ | 5.12▲ |
MA20 | 6.00▼ | 6.20▼ | 6.19▼ | 5.55▲ | 4.12▲ |
MA50 | 6.05▼ | 6.05▼ | 5.90▼ | 4.94▲ | 2.63▲ |
MA100 | 6.17▼ | 5.88▼ | 5.62▲ | 3.92▲ | 2.09▲ |
MA200 | 6.24▼ | 5.59▲ | 5.29▲ | 2.77▲ | 2.55▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.009▼ | -0.046▼ | -0.067▼ | 0.041▲ | 0.145▲ |
RSI | 28.397▼ | 35.088▼ | 41.481▼ | 56.538▲ | 72.876▲ |
STOCH | 18.183▼ | 27.987 | 16.140▼ | 68.263 | 75.508 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -50.063 | -23.848▲ |
CCI | -132.897▼ | -177.246▼ | -130.000▼ | 87.785 | 151.403▲ |
Monday, October 20, 2025 03:29 PM
Investing.com -- ATAI Life Sciences (NASDAQ:ATAI) stock gained 2% in after-hours trading Monday following the company’s announcement that it has closed its public offering of 27.28 million common ...
|
Monday, October 20, 2025 02:30 PM
Jefferies LLC acted as the lead bookrunner for the offering. Berenberg Capital Markets LLC acted as passive bookrunner for the offering. Oppenheimer & Co. Inc. and Canaccord Genuity LLC acted as ...
|
Monday, October 20, 2025 06:01 AM
Discover ATAI’s pipeline, including promising BPL-003 for TRD, upcoming Phase 3 trials, and a merger with Beckley Psytech.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/10/25 | 6.56 | 6.56 | 5.86 | 5.87 | 7,885,914 |
20/10/25 | 6.70 | 6.75 | 6.28 | 6.42 | 10,318,768 |
17/10/25 | 5.535 | 6.5452 | 5.38 | 6.45 | 31,255,367 |
16/10/25 | 6.00 | 6.09 | 5.475 | 5.48 | 6,642,338 |
15/10/25 | 6.12 | 6.30 | 5.835 | 5.96 | 6,306,242 |
14/10/25 | 5.35 | 6.2399 | 5.34 | 6.00 | 9,789,703 |
13/10/25 | 5.21 | 5.43 | 5.06 | 5.40 | 5,253,795 |
10/10/25 | 5.45 | 5.4821 | 5.09 | 5.10 | 4,610,157 |
09/10/25 | 5.65 | 5.8299 | 5.3616 | 5.45 | 4,616,948 |
08/10/25 | 5.57 | 5.6132 | 5.38 | 5.58 | 3,910,266 |
|
|
||||
|
|
||||
|
|